375 related articles for article (PubMed ID: 3872316)
21. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid.
Hirst MA; Hochman HI; Feldman D
J Clin Endocrinol Metab; 1985 Mar; 60(3):490-5. PubMed ID: 2982898
[TBL] [Abstract][Full Text] [Related]
22. Hereditary 1,25-dihydroxyvitamin D-resistant rickets due to an opal mutation causing premature termination of the vitamin D receptor.
Zhu W; Malloy PJ; Delvin E; Chabot G; Feldman D
J Bone Miner Res; 1998 Feb; 13(2):259-64. PubMed ID: 9495519
[TBL] [Abstract][Full Text] [Related]
23. Autocrine control of vitamin D metabolism in synovial cells from arthritic patients.
Smith SJ; Hayes ME; Selby PL; Mawer EB
Ann Rheum Dis; 1999 Jun; 58(6):372-8. PubMed ID: 10340962
[TBL] [Abstract][Full Text] [Related]
24. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
Chen TL; Hauschka PV; Cabrales S; Feldman D
Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
[TBL] [Abstract][Full Text] [Related]
25. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
[TBL] [Abstract][Full Text] [Related]
26. Regulation of vitamin D-responsive gene expression by fluorinated analogs of calcitriol in rat osteoblastic ROB-C26 cells.
Miyamoto Y; Shinki T; Ohyama Y; Kasama T; Iwasaki H
J Biochem; 1995 Nov; 118(5):1068-76. PubMed ID: 8749328
[TBL] [Abstract][Full Text] [Related]
27. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus.
St-Arnaud R; Messerlian S; Moir JM; Omdahl JL; Glorieux FH
J Bone Miner Res; 1997 Oct; 12(10):1552-9. PubMed ID: 9333115
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D.
Marx SJ; Bliziotes MM; Nanes M
Clin Endocrinol (Oxf); 1986 Oct; 25(4):373-81. PubMed ID: 3040300
[TBL] [Abstract][Full Text] [Related]
29. Studies on an adherent variant of the human promyelomonocytic HL60 leukaemia cell line that constitutively expresses 25-hydroxyvitamin D3-24-hydroxylase activity which is inhibited by 1 alpha,25-dihydroxyvitamin D3.
Hayes ME; Bayley D; Mawer EB
J Mol Endocrinol; 1991 Dec; 7(3):185-95. PubMed ID: 1777040
[TBL] [Abstract][Full Text] [Related]
30. Effects of 1,25-dihydroxyvitamin D3 and phorbol ester on 25-hydroxyvitamin D3 24-hydroxylase cytochrome P450 messenger ribonucleic acid levels in primary cultures of rat renal cells.
Chen ML; Boltz MA; Armbrecht HJ
Endocrinology; 1993 Apr; 132(4):1782-8. PubMed ID: 7681765
[TBL] [Abstract][Full Text] [Related]
31. Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II.
Malloy PJ; Hochberg Z; Pike JW; Feldman D
J Clin Endocrinol Metab; 1989 Feb; 68(2):263-9. PubMed ID: 2537329
[TBL] [Abstract][Full Text] [Related]
32. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level.
Chen TL; Li JM; Ye TV; Cone CM; Feldman D
J Cell Physiol; 1986 Jan; 126(1):21-8. PubMed ID: 3003120
[TBL] [Abstract][Full Text] [Related]
33. A variant form of the 1,25-dihydroxyvitamin D3 receptor with low apparent hormone affinity in cultured monkey kidney cells (LLC-MK2). A model for tissue resistance to vitamin D.
Kelly MA; Marion SL; Donaldson CA; Pike JW; Haussler MR
J Biol Chem; 1985 Feb; 260(3):1545-9. PubMed ID: 2981861
[TBL] [Abstract][Full Text] [Related]
34. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
35. Regulation of 1,25-dihydroxyvitamin D3 receptors by vitamin D analogs in cultured mammalian cells.
Costa EM; Hirst MA; Feldman D
Endocrinology; 1985 Nov; 117(5):2203-10. PubMed ID: 2995009
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 and its sensitivity to ketoconazole in 1 alpha,25-dihydroxyvitamin D3-differentiated HL60 cells.
Hayes ME; Bayley D; Mawer EB
J Mol Endocrinol; 1989 Nov; 3(3):199-205. PubMed ID: 2590383
[TBL] [Abstract][Full Text] [Related]
37. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor.
Barsony J; McKoy W; DeGrange DA; Liberman UA; Marx SJ
J Clin Invest; 1989 Jun; 83(6):2093-101. PubMed ID: 2542381
[TBL] [Abstract][Full Text] [Related]
38. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line.
Bland R; Zehnder D; Hughes SV; Ronco PM; Stewart PM; Hewison M
Kidney Int; 2001 Oct; 60(4):1277-86. PubMed ID: 11576342
[TBL] [Abstract][Full Text] [Related]
39. Characterization of vitamin D-mediated induction of the CYP 24 transcription.
Tashiro K; Abe T; Oue N; Yasui W; Ryoji M
Mol Cell Endocrinol; 2004 Oct; 226(1-2):27-32. PubMed ID: 15489002
[TBL] [Abstract][Full Text] [Related]
40. Calcitriol regulates the expression of the genes encoding the three key vitamin D3 hydroxylases and the drug-metabolizing enzyme CYP3A4 in the human fetal intestine.
Theodoropoulos C; Demers C; Delvin E; Ménard D; Gascon-Barré M
Clin Endocrinol (Oxf); 2003 Apr; 58(4):489-99. PubMed ID: 12641633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
